LeMaitre Vascular Sees Q4 EPS $0.34-$0.38 Vs $0.34 Est.; Revenue $48M-50M Vs $50.19M Est.; FY23 EPS $1.32-$1.36 Vs $1.28 Est. Revenue $192.6M-$194.6M Vs $195.01M Est.
Portfolio Pulse from Benzinga Newsdesk
LeMaitre Vascular has provided its Q4 and FY23 guidance. For Q4, it expects EPS of $0.34-$0.38 (vs $0.34 estimated) and revenue of $48M-$50M (vs $50.19M estimated). For FY23, it expects EPS of $1.32-$1.36 (vs $1.28 estimated) and revenue of $192.6M-$194.6M (vs $195.01M estimated). The company also mentioned special charges related to the St. Etienne factory closure.
November 01, 2023 | 9:43 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
LeMaitre Vascular's Q4 and FY23 guidance is slightly below estimates. However, the EPS guidance for both periods is higher than estimates, which could have a positive impact on the stock.
The company's revenue guidance for both Q4 and FY23 is slightly below estimates, which could be seen as a negative by investors. However, the EPS guidance for both periods is higher than estimates, which is a positive sign and could outweigh the lower revenue guidance. Therefore, the overall impact on the stock is likely to be positive.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100